Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Geron Corp (GERN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 595,395
  • Shares Outstanding, K 173,080
  • Annual Sales, $ 1,070 K
  • Annual Income, $ -27,920 K
  • 36-Month Beta 2.57
  • Price/Sales 588.31
  • Price/Cash Flow N/A
  • Price/Book 5.75

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.32 +6.02%
on 06/28/18
4.59 -23.31%
on 06/18/18
-0.76 (-17.76%)
since 06/15/18
3-Month
3.23 +8.98%
on 05/17/18
5.17 -31.91%
on 05/24/18
-0.47 (-11.78%)
since 04/17/18
52-Week
1.74 +102.30%
on 11/14/17
6.68 -47.31%
on 03/22/18
+0.66 (+23.08%)
since 07/17/17

Most Recent Stories

More News
Are Options Traders Betting on a Big Move in Geron (GERN) Stock?

Investors in Geron (GERN) need to pay close attention to the stock based on moves in the options market lately.

GERN : 3.54 (+2.91%)
These Biotech Companies are a Treat for Investors

HENDERSON, NV / ACCESSWIRE / July 8, 2018 / In order to take a drug to market the cost was estimated to be $2.4 billion. This has caused many biotech firms to enter the device market, rather than drug...

GERN : 3.54 (+2.91%)
Today's Research Reports on Trending Tickers: Geron and Celgene

NEW YORK, NY / ACCESSWIRE / July 2, 2018 / Major U.S. markets finished higher on Friday, but finished the week lower due to ongoing global trade concerns. The Dow Jones Industrial Average increased 0.23...

GERN : 3.54 (+2.91%)
CELGZ : 0.65 (+1.56%)
Today's Research Reports on Stocks to Watch: Geron Corporation and BioMarin Pharmaceutical

NEW YORK, NY / ACCESSWIRE / June 18, 2018 / Biotech stocks Geron Corporation and BioMarin Pharmaceutical were both rising in Friday's trading session with gains of almost 10% by the close of the day. While...

GERN : 3.54 (+2.91%)
Geron Reports Imetelstat Oral Presentation at European Hematology Association Congress

Geron Corporation (Nasdaq:GERN) today announced the oral presentation of updated data from the ongoing original Part 1 of IMerge, the Phase 2/3 trial of imetelstat in lower risk myelodysplastic syndromes...

GERN : 3.54 (+2.91%)
Free Technical Reports on Gilead Sciences and Three Additional Biotech Equities

Stock Research Monitor: GERN, GBT, and GLYC

GBT : 40.15 (+1.52%)
GERN : 3.54 (+2.91%)
GILD : 77.12 (-0.18%)
Today's Research Reports on Trending Tickers: Geron and Forward Pharma

NEW YORK, NY / ACCESSWIRE / May 23, 2018 / U.S. markets fell Tuesday on geopolitical concerns after President Trump stated he was not happy with the current U.S. - China trade talks. The Dow Jones Industrial...

GERN : 3.54 (+2.91%)
Implied Volatility Surging for Geron (GERN) Stock Options

Geron (GERN) needs investors to pay close attention to the stock based on moves in the options market lately.

GERN : 3.54 (+2.91%)
Is Geron (GERN) Outperforming Other Medical Stocks This Year?

Is Geron Corporation (GERN) Outperforming Other Medical Stocks This Year?

GERN : 3.54 (+2.91%)
Geron (GERN) Q1 Loss Narrows Y/Y, Revenues Fall, Shares Down

Geron (GERN) beats earnings but on lower sales in Q1. Operating expenses were lower year over year.

LGND : 220.01 (+0.09%)
ENTA : 120.78 (-0.20%)
JNJ : 129.33 (+3.72%)
GERN : 3.54 (+2.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade GERN with:

Business Summary

Geron Corporation is a scientific research company that is developing techniques for the health services industry. Their research is currently divided in three different areas. First, they are looking into telomeres and telomerase and their roles in cellular aging and cancer. Second, they are looking...

See More

Key Turning Points

2nd Resistance Point 3.76
1st Resistance Point 3.60
Last Price 3.54
1st Support Level 3.35
2nd Support Level 3.26

See More

52-Week High 6.68
Fibonacci 61.8% 4.79
Fibonacci 50% 4.21
Fibonacci 38.2% 3.63
Last Price 3.54
52-Week Low 1.74

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar